JP7329474B2 - Anti-aging cosmetic composition - Google Patents
Anti-aging cosmetic composition Download PDFInfo
- Publication number
- JP7329474B2 JP7329474B2 JP2020055582A JP2020055582A JP7329474B2 JP 7329474 B2 JP7329474 B2 JP 7329474B2 JP 2020055582 A JP2020055582 A JP 2020055582A JP 2020055582 A JP2020055582 A JP 2020055582A JP 7329474 B2 JP7329474 B2 JP 7329474B2
- Authority
- JP
- Japan
- Prior art keywords
- birch sap
- aging
- sap
- oil
- birch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 58
- 230000003712 anti-aging effect Effects 0.000 title claims description 48
- 239000002537 cosmetic Substances 0.000 title claims description 30
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 65
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000037303 wrinkles Effects 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 239000002994 raw material Substances 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 15
- 239000012071 phase Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 239000006071 cream Substances 0.000 description 11
- 238000004945 emulsification Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- -1 isopropyl lauroyl Chemical group 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000011550 stock solution Substances 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 8
- 210000002950 fibroblast Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000010998 test method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 6
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000037067 skin hydration Effects 0.000 description 5
- 235000002992 Betula pubescens Nutrition 0.000 description 4
- 241001520764 Betula pubescens Species 0.000 description 4
- 238000008157 ELISA kit Methods 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000219495 Betulaceae Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000004266 Collagen Type IV Human genes 0.000 description 3
- 108010042086 Collagen Type IV Proteins 0.000 description 3
- 102000007547 Laminin Human genes 0.000 description 3
- 108010085895 Laminin Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940105132 myristate Drugs 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 230000009758 senescence Effects 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- 235000003320 Adansonia digitata Nutrition 0.000 description 2
- 244000056974 Adansonia digitata Species 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 102000001187 Collagen Type III Human genes 0.000 description 2
- 108010069502 Collagen Type III Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 235000004496 Oenothera biennis Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- OGNHOGPWQTWKGQ-VGWMRTNUSA-N (2S)-5-amino-2-[[(2S)-1-[2-[[(2S)-5-amino-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 OGNHOGPWQTWKGQ-VGWMRTNUSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 description 1
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 1
- LODWEXDBRZBADB-XEVVZDEMSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O LODWEXDBRZBADB-XEVVZDEMSA-N 0.000 description 1
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 description 1
- VCLJODPNBNEBKW-UHFFFAOYSA-N 2,2,4,4,6,8,8-heptamethylnonane Chemical compound CC(C)(C)CC(C)CC(C)(C)CC(C)(C)C VCLJODPNBNEBKW-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- GJVUMEONPPTZEY-UHFFFAOYSA-N 2,3-dihydroxypropyl undec-10-enoate Chemical compound OCC(O)COC(=O)CCCCCCCCC=C GJVUMEONPPTZEY-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- AAOFEMJZTYQZRH-UHFFFAOYSA-N 2-(1-butoxypropan-2-yloxy)ethanol Chemical compound CCCCOCC(C)OCCO AAOFEMJZTYQZRH-UHFFFAOYSA-N 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000003319 Adansonia gregorii Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000125300 Argania sideroxylon Species 0.000 description 1
- 235000016108 Argania sideroxylon Nutrition 0.000 description 1
- 241000238582 Artemia Species 0.000 description 1
- 241000454552 Astrocaryum murumuru Species 0.000 description 1
- 235000000016 Astrocaryum murumuru Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- DBFHTTOOJDMDTI-KCMGSBMCSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO DBFHTTOOJDMDTI-KCMGSBMCSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000007460 Coffea arabica Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 102000004510 Collagen Type VII Human genes 0.000 description 1
- 108010017377 Collagen Type VII Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000001534 FEMA 4201 Substances 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 241000510609 Ferula Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000015164 Iris germanica var. florentina Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 244000223604 Mauritia flexuosa Species 0.000 description 1
- 235000010080 Mauritia flexuosa Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 240000008916 Oenothera biennis Species 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000010453 Pterocarpus marsupium Nutrition 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 235000000539 Rosa canina Nutrition 0.000 description 1
- 240000008530 Rosa canina Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LZDNBBYBDGBADK-KBPBESRZSA-N Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-KBPBESRZSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 1
- NENOAJSZZPODGJ-OIMNJJJWSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NENOAJSZZPODGJ-OIMNJJJWSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- ZQTUNIWBUQUKAM-UHFFFAOYSA-N [3-[2-(1h-imidazol-1-ium-4-yl)ethylamino]-3-oxopropyl]azanium;dichloride Chemical compound Cl.Cl.NCCC(=O)NCCC1=CN=CN1 ZQTUNIWBUQUKAM-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- HSUGRPOJOBRRBK-SXBSVMRRSA-N acetic acid;(2s)-n-[(2s)-4-amino-1-(benzylamino)-1-oxobutan-2-yl]-1-(3-aminopropanoyl)pyrrolidine-2-carboxamide Chemical compound CC(O)=O.CC(O)=O.N([C@@H](CCN)C(=O)NCC=1C=CC=CC=1)C(=O)[C@@H]1CCCN1C(=O)CCN HSUGRPOJOBRRBK-SXBSVMRRSA-N 0.000 description 1
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940011403 apple seed extract Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-L cyclohexane-1,4-dicarboxylate Chemical compound [O-]C(=O)C1CCC(C([O-])=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-L 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229940093497 ergothioneine Drugs 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940088638 glycereth-7 Drugs 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 244000023249 iris florentino Species 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 1
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 description 1
- 229940094912 palmitoyl tripeptide-5 Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940078492 ppg-17 Drugs 0.000 description 1
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 description 1
- 229940047663 ppg-26-buteth-26 Drugs 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、濃縮カバノキ樹液、及び濃縮カバノキ樹液を含むアンチエイジング化粧品組成物に関する。 The present invention relates to concentrated birch sap and anti-aging cosmetic compositions comprising concentrated birch sap.
カバノキはカバノキ科の落葉樹であり、現在世界中に約100種が存在し、主に北部温帯及び冷温帯に分布している。その中でも、中国には約29種が存在し、主に北東部、北西部及び南西部に分布している。カバノキの木は主に、人の干渉がほとんどなく、産業汚染のない人里離れた山岳地帯で成長している。カバノキ樹液(バーチジュースとも呼ばれる)は、切断されたカバノキ樹皮又は穴を開けた幹からの新鮮な樹液である。カバノキ樹液は無色又は淡黄色で、沈殿物も不純物もなく、淡いカバノキの芳香がある。カバノキ樹液は、糖、アミノ酸、ビタミン、ビオチン、サイトカイニン、微量ミネラル元素、芳香油、ベツリン及びサポニンなどの多数の化合物を含有し、優れたアンチエイジング効果を有する。 Birch is a deciduous tree belonging to the Betulaceae family, and currently there are about 100 species in the world, which are mainly distributed in the northern temperate zone and the cool temperate zone. Among them, there are about 29 species in China, mainly distributed in the northeast, northwest and southwest. Birch trees grow mainly in remote mountainous areas with little human intervention and no industrial pollution. Birch sap (also called birch juice) is the fresh sap from the cut birch bark or pierced trunk. Birch sap is colorless or pale yellow with no sediment or impurities and has a faint birch fragrance. Birch sap contains numerous compounds such as sugars, amino acids, vitamins, biotin, cytokinins, trace mineral elements, aromatic oils, betulin and saponins, and has excellent anti-aging effects.
皮膚の老化は、身体を保護及び調節する皮膚の能力の低下を意味し、したがって、内部及び外部環境の変化に適応できず、皮膚の色及び状態などの全体的な外観のいくらかの変化を示し、その結果、皮膚の弾力性の低下又は消失、皮膚のたるみ、しわの増加、乾燥肌、菲薄化、容易な落屑、かゆみ、くすんだ肌色、つやのなさ、ならびに濃い斑点及びいぼの併発をもたらす。人口の高齢化及び生活水準の継続的な改善に伴い、消費者の抗しわに対する意識は高まり続けており、ますます多くの消費者が、若い外観を維持するための化粧品を使用したがっている。統計によると、アンチエイジング化粧品は、中国の化粧品市場で最も成長が早く、最も有望なカテゴリーになっている。 Aging of the skin means a reduction in the ability of the skin to protect and regulate the body, thus being unable to adapt to changes in the internal and external environment and exhibiting some changes in overall appearance such as skin color and condition. , resulting in reduced or lost skin elasticity, sagging skin, increased wrinkling, dry skin, thinning, easy scaling, itching, dull complexion, dullness, and concomitant dark spots and warts. As the population ages and living standards continue to improve, consumer awareness of anti-wrinkle continues to grow, and more and more consumers want to use cosmetics to maintain a youthful appearance. Statistics show that anti-aging cosmetics have become the fastest growing and most promising category in China's cosmetics market.
一態様では、本発明は、1.05~8倍、好ましくは1.1~4倍、より好ましくは1.2~2倍の濃縮度を有する濃縮カバノキ樹液を提供する。濃縮カバノキ樹液は有意なアンチエイジング効果を有する。 In one aspect, the present invention provides a concentrated birch sap having a degree of enrichment of 1.05-8 fold, preferably 1.1-4 fold, more preferably 1.2-2 fold. Concentrated birch sap has significant anti-aging effects.
本発明に関与するカバノキ樹液は、ベタラアルバ(Betalaalba)、ヨーロッパダケカンバ(Betula pubescens)、ベチュラ・ペンデュラ(Betula Pendula)及びシラカンバ(Betula platyphylla)の4つの変種を含むカバノキ科(Betulaceae)カバノキ属(Betula)から得られる。カバノキ樹液は、雪が溶け始めてから木が葉を出すまで、カバノキの木の幹の基部に人工的に穴を開けて、ここから回収することによって得られる沈殿物も不純物もない無色透明で栄養価の高いカバノキ樹液である。カバノキ樹液は市販されており、そのまま使用されており(この場合、これはまた非濃縮カバノキ樹液、又はカバノキ樹液原液とも呼ばれる)、例えば、Daxinganling Chaoyue Wild Berry Development Co.,Ltdから購入することができる。 The birch sap involved in the present invention is of the genus Betulaceae of the family Betulaceae, which includes four varieties: Betalaalba, Betula pubescens, Betula Pendula and Betula platyphylla. ula) obtained from Birch sap is obtained by artificially drilling holes in the base of birch tree trunks from the time the snow begins to melt until the trees begin to put out leaves. is high in birch sap. Birch sap is commercially available and used as is (in which case it is also called unconcentrated birch sap, or birch sap undiluted solution), for example from Daxinganling Chaoyue Wild Berry Development Co. , Ltd.
本発明で使用される濃縮カバノキ樹液は、上記の市販のカバノキ樹液原液製品を濃縮することによって得られる。加熱濃縮、低温及び真空濃縮、ならびに膜濃縮などの濃縮方法は、当技術分野で知られている。本発明では、濃縮が、好ましくは低温凍結濃縮又は膜濃縮プロセスによって行われる。例えば、市販のカバノキ樹液原液を低温乾燥装置に導入し、-40~-70℃に冷却し、低温及び真空濃縮プロセスのために0.1~30Paに真空引きして、様々な濃縮度を有する濃縮カバノキ樹液を得る。 The concentrated birch sap used in the present invention is obtained by concentrating the commercially available birch sap stock product described above. Concentration methods such as thermal concentration, cryogenic and vacuum concentration, and membrane concentration are known in the art. In the present invention, concentration is preferably performed by a cryogenic freeze concentration or membrane concentration process. For example, a commercially available birch sap stock solution is introduced into a low temperature drying device, cooled to -40 to -70°C, and vacuumed to 0.1 to 30 Pa for the low temperature and vacuum concentration process, with various degrees of concentration. Obtain concentrated birch sap.
本発明者らは、驚くべきことに、非濃縮カバノキ樹液原液と比較して、濃縮カバノキ樹液が有意に優れた保湿及びアンチエイジング効果を有し、細胞外マトリックス中のI型、III型、IV型、VII型、XVII型コラーゲン、エラスチン及びラミニンの合成を促進し、マトリックスメタロプロテイナーゼMMP-1の発現を低下させ、ヒアルロン酸の産生を促進し、表皮、真皮、及び真皮-表皮接合部の構造的完全性及び機能性を強化し、皮膚の弾力性を改善し、しわを減らすと同時に、皮膚のバリアを改善し、経表皮水分蒸散量(transepidermal water loss)を減らし、抗炎症及び鎮静化の機能を有することができることを発見した。 The present inventors have surprisingly found that concentrated birch sap has significantly better moisturizing and anti-aging effects compared to unconcentrated birch sap stock solution, demonstrating that type I, III, IV Promotes synthesis of type, VII, XVII collagen, elastin and laminin, reduces expression of matrix metalloproteinase MMP-1, promotes production of hyaluronic acid, structures of the epidermis, dermis, and dermal-epidermal junction enhance skin integrity and functionality, improve skin elasticity, reduce wrinkles while improving skin barrier, reducing transepidermal water loss, anti-inflammatory and soothing I discovered that it can have a function.
さらに、本発明者らはまた、濃縮カバノキ樹液のアンチエイジング効果が、その濃縮度と単純に線形に関連するのではなく、最初に増加し、次いで、濃縮度が増加するにつれて減少する傾向を示す、すなわち、カバノキ樹液の濃縮度が一定のレベルに達すると、濃縮カバノキ樹液は細胞の増殖及び生存率をある程度抑制し、細胞内外の老化関連遺伝子の発現を抑制することを発見した。したがって、カバノキ樹液の濃縮度を制御することが重要である。本発明では、カバノキ樹液の濃縮度を、約1.05~8倍、好ましくは約1.1~4倍、より好ましくは約1.2~2倍に制御する。 Furthermore, we also show that the anti-aging effect of concentrated birch sap is not simply linearly related to its concentration, but tends to first increase and then decrease with increasing concentration. That is, when the concentration of birch sap reaches a certain level, the concentrated birch sap suppresses cell proliferation and viability to some extent, and suppresses the expression of senescence-related genes inside and outside cells. Therefore, it is important to control the concentration of birch sap. In the present invention, the concentration of birch sap is controlled to about 1.05 to 8 times, preferably about 1.1 to 4 times, more preferably about 1.2 to 2 times.
別の態様では、本発明は、アンチエイジング化粧品組成物における濃縮カバノキ樹液の使用に関する。 In another aspect, the present invention relates to the use of concentrated birch sap in anti-aging cosmetic compositions.
さらに別の態様では、本発明は、(A)上記の濃縮カバノキ樹液を含むアンチエイジング化粧品組成物に関する。 In yet another aspect, the present invention relates to an anti-aging cosmetic composition comprising (A) the concentrated birch sap described above.
好ましい実施形態では、アンチエイジング化粧品組成物が、EDTA塩、ポリリン酸ナトリウム、メタリン酸ナトリウム及びグルコン酸等などのキレート剤を含まない。 In a preferred embodiment, the anti-aging cosmetic composition is free of chelating agents such as EDTA salts, sodium polyphosphate, sodium metaphosphate and gluconic acid.
アンチエイジング化粧品組成物は、さらに添加される水を含まないが、組成物の成分の各々に本質的に含まれる水分を排除しない。 The anti-aging cosmetic composition does not contain added water, but does not exclude the water inherent in each of the composition's components.
濃縮カバノキ樹液の含有量は、アンチエイジング化粧品組成物の総重量基準で約18~98重量%、好ましくは20~95重量%、より好ましくは22~90重量%、最も好ましくは30~90重量%である。 The content of concentrated birch sap is about 18-98% by weight, preferably 20-95% by weight, more preferably 22-90% by weight, most preferably 30-90% by weight, based on the total weight of the anti-aging cosmetic composition. is.
成分(A)上記の濃縮カバノキ樹液に加えて、アンチエイジング化粧品組成物は、場合により(B)ビヒクル、有効成分、及び賦形剤を含むスキンケア化粧品組成物で一般的に使用される成分をさらに含んでもよい。成分(B)は当技術分野で既知であり、その種類及び量は必要に応じて当業者が選択することができる。例えば、成分(B)の含有量は、アンチエイジング化粧品組成物の総重量基準で約2~82重量%である。 Component (A) In addition to the concentrated birch sap described above, the anti-aging cosmetic composition optionally further comprises components commonly used in skin care cosmetic compositions, including (B) a vehicle, an active ingredient, and an excipient. may contain. Component (B) is known in the art, and its type and amount can be selected by those skilled in the art according to need. For example, the content of component (B) is about 2-82% by weight based on the total weight of the anti-aging cosmetic composition.
ビヒクルには、例えば、希釈剤、分散剤、又は担体が含まれる。その例としては、それだけに限らないが、エタノール、ジプロピレングリコール、及びブタンジオールが挙げられる。化粧品組成物中のビヒクルの含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で0.5~20%である。 Vehicles include, for example, diluents, dispersants, or carriers. Examples include, but are not limited to, ethanol, dipropylene glycol, and butanediol. The content of vehicles in cosmetic compositions is known in the art, eg typically 0.5-20% based on the total weight of component (B).
有効成分には、例えば、皮膚軟化剤、保湿剤、アンチエイジング有効成分等が含まれる。 Active ingredients include, for example, emollients, moisturizers, anti-aging active ingredients, and the like.
皮膚軟化剤の例としては、それだけに限らないが、オリーブ油、マカダミアナッツ油、スイートアーモンド油、グレープシード油、アボカド油、コーン油、ゴマ油、大豆油、ピーナッツ油、メドウフォーム種子油、ベニバナ種子油、イヌバラ(Rosa canina)果実油、アルガニア・スピノサ(Argania spinosa)核油、ホホバ(Simmondsia chinensis)種子油、ヒマワリ種子油、オオミテングヤシ(Mauritia flexuosa)果実油、スクアラン、パルミチン酸エチルヘキシル、ミリスチン酸イソプロピル、水素化ポリイソブチレン、イソセタン、イソドデカン、炭酸ジエチルヘキシル、炭酸ジオクチル、ラウロイルサルコシンイソプロピル、イソノナン酸イソノニル、水素化ポリデセン、トリエチルヘキサノイン、ヘキサン酸セチルエチル、ビス-ジエトキシジグリコールシクロヘキサン1,4-ジカルボキシラート、カプリル酸/カプリン酸トリグリセリド、エルカ酸オレイル、オクチルドデカノールミリスタート、オクチルドデカノール、ポリジメチルシロキサン、オクチルポリメチルシロキサン、セチルジメチコン、シクロペンタジメチルシロキサンなどが挙げられる。固体皮膚軟化剤の例としては、それだけに限らないが、セチルアルコール、ステアリルアルコール、セテアリルアルコール、ベヘニルアルコール、スクアリルアルコール、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、蜜蝋、カンデリラ蝋、カルナウバ蝋、ラノリン、オゾケライト、ホホバ種子ワックス、パラフィンワックス、ミクロクリスタリンワックス、水添コメヌカロウ、水添ココグリセリル、ベヘン酸/エイコサン二酸グリセリル、ミリスチン酸ミリスチル、ビス-ジグリセリルポリアシルアジパート-2、ブチロスパーマム・パーキー(butyrospermum parkii)(シアバター)、及びアストロカリウムムルムル(astrocaryum murumuru)種子脂の1つ又は複数が挙げられる。化粧品組成物中の皮膚軟化剤の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で1~50%である。 Examples of emollients include, but are not limited to, olive oil, macadamia nut oil, sweet almond oil, grape seed oil, avocado oil, corn oil, sesame oil, soybean oil, peanut oil, meadowfoam seed oil, safflower seed oil, Rosa canina fruit oil, Argania spinosa kernel oil, Simmondsia chinensis seed oil, sunflower seed oil, Mauritia flexuosa fruit oil, squalane, ethylhexyl palmitate, isopropyl myristate, hydrogenated Polyisobutylene, isocetane, isododecane, diethylhexyl carbonate, dioctyl carbonate, isopropyl lauroyl sarcosine, isononyl isononanoate, polydecene hydrogenation, triethylhexanoin, cetyl ethyl hexanoate, bis-diethoxydiglycol cyclohexane 1,4-dicarboxylate, capryl acid/capric acid triglyceride, oleyl erucate, octyldodecanol myristate, octyldodecanol, polydimethylsiloxane, octylpolymethylsiloxane, cetyldimethicone, cyclopentadimethylsiloxane, and the like. Examples of solid emollients include, but are not limited to, cetyl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, squalyl alcohol, lauric acid, myristic acid, palmitic acid, stearic acid, beeswax, candelilla wax, carnauba wax, Lanolin, ozokerite, jojoba seed wax, paraffin wax, microcrystalline wax, hydrogenated rice bran wax, hydrogenated cocoglyceryl, glyceryl behenate/eicosanedioate, myristyl myristate, bis-diglyceryl polyacyl adipate-2, butyrospermum perky (butyrospermum parkii) (shea butter), and astrocaryum murumuru seed oil. The content of emollients in cosmetic compositions is known in the art, eg typically 1-50% based on the total weight of component (B).
保湿剤の例としては、それだけに限らないが、グリセロール、ジグリセロール、ブタンジオール、プロピレングリコール、1,3-プロパンジオール、ジプロピレングリコール、1,2-ペンタンジオール、ポリエチレングリコール-8、ポリエチレングリコール-32、メチルグルセス-10、メチルグルセス-20、PEG/PPG-17/6コポリマー、グリセレス-7、グリセレス-26、グリセリルグルコシド、PPG-10メチルグルコースエーテル、PPG-20メチルグルコースエーテル、PEG/PPG/ポリブチレングリコール-8/5/3グリセロール、スクロース、トレハロース、ラムノース、マンノース、ラフィノース、ベタイン、エリスリトール、キシリトール、尿素、乳酸グリセレス-5、ヒアルロン酸ナトリウム、加水分解ヒアルロン酸ナトリウム、アセチル化ヒアルロン酸ナトリウム、ポリグルタミン酸ナトリウム、加水分解スクレロチウムガム、プルラン、トレメラム(tremellam)、及びタマリンド(tamarindus indica)種子多糖体の1つ又は複数が挙げられる。化粧品組成物中の保湿剤の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で1~30%である。 Examples of humectants include, but are not limited to, glycerol, diglycerol, butanediol, propylene glycol, 1,3-propanediol, dipropylene glycol, 1,2-pentanediol, polyethylene glycol-8, polyethylene glycol-32. , methylgluceth-10, methylgluceth-20, PEG/PPG-17/6 copolymer, glycereth-7, glycereth-26, glyceryl glucoside, PPG-10 methylglucose ether, PPG-20 methylglucose ether, PEG/PPG/polybutylene glycol - 8/5/3 Glycerol, Sucrose, Trehalose, Rhamnose, Mannose, Raffinose, Betaine, Erythritol, Xylitol, Urea, Glycereth-5 Lactate, Sodium Hyaluronate, Sodium Hydrolyzed Hyaluronate, Sodium Acetylated Hyaluronate, Sodium Polyglutamate , hydrolyzed sclerotium gum, pullulan, tremellam, and tamarindus indica seed polysaccharides. The content of humectants in cosmetic compositions is known in the art, eg typically 1-30% based on the total weight of component (B).
アンチエイジング有効成分の例としては、それだけに限らないが、トコフェロール(ビタミンE)、レチノール、パルミチン酸レチニル、加水分解コラーゲン、加水分解エラスチン、アラントイン、酵母エキス、オリザノール、テトラヒドロクルクミン、エラグ酸、ユビキノン、乳清タンパク質、アセチルヘキサペプチド-8、パルミトイルペンタペプチド-4、サリチロイルフィトスフィンゴシン、濃縮カバノキ樹液、シリマリン、セリシン、トコフェリルリン酸ナトリウム、リボ核酸(RNA)、ジペプチドジアミノブチロイルベンジルアミドジアセタート、パルミトイルトリペプチド-5、オリゴペプチド-1、ヘキサペプチド-9、パルミトイルオリゴペプチド、パルミトイルテトラペプチド-7、ブドウ(Vitis vinifera)種子抽出物、プロテカルプス(Pterocarpus marsupium)樹皮抽出物、チャノキ(Camellia sinensis)ポリフェノール、ワイン抽出物、リンゴ種子抽出物、ヨーロッパブナ(Fagus sylvatica)芽抽出物、アフリカバオバブ(Adansonia digitata)抽出物、アルテミア(Artemia)抽出物、イリス・フロレンティナ(Iris florentina)根抽出物、ヘスペリジン、ジンセノシド、タンジン(Salvia miltiorrhiza)抽出物、ニコチンアミド、ウルソール酸、ヒアルロン酸ナトリウム、アセチル化ヒアルロン酸ナトリウム、加水分解ヒアルロン酸ナトリウム、リコペン、コーヒーノキ(Coffea arabica)抽出物、ジペプチド-2、乳酸、スーパーオキシドジスムターゼ(SOD)、メマツヨイグサ(Oenothera biennis)油、セラミド、ジパルミトイルヒドロキシプロリン、ヒドロキシステアリン酸、サリチル酸、エルゴチオネイン、リゾレシチン、カルノシン、デカルボキシカルノシンHCL、リポ酸、アデノシン、グリコーゲン、レスベラトロール、フェルラ酸、ビフィズス菌培養溶解緩衝液及び乳酸球菌培養溶解緩衝液の1つ又は複数が挙げられる。化粧品組成物中のアンチエイジング有効成分の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で0.01~10%である。 Examples of anti-aging active ingredients include, but are not limited to, tocopherol (vitamin E), retinol, retinyl palmitate, hydrolyzed collagen, hydrolyzed elastin, allantoin, yeast extract, oryzanol, tetrahydrocurcumin, ellagic acid, ubiquinone, milk. Pure protein, acetyl hexapeptide-8, palmitoyl pentapeptide-4, salicylophytosphingosine, birch sap concentrate, silymarin, sericin, sodium tocopheryl phosphate, ribonucleic acid (RNA), dipeptide diaminobutyroylbenzylamide diacetate , palmitoyl tripeptide-5, oligopeptide-1, hexapeptide-9, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, grape (Vitis vinifera) seed extract, protecarpus (Pterocarpus marsupium) bark extract, tea tree (Camellia sinensis) ) polyphenols, wine extract, apple seed extract, Fagus sylvatica bud extract, African baobab (Adansonia digitata) extract, Artemia extract, Iris florentina root extract, hesperidin, ginsenosides, Salvia miltiorrhiza extract, nicotinamide, ursolic acid, sodium hyaluronate, acetylated sodium hyaluronate, hydrolyzed sodium hyaluronate, lycopene, Coffea arabica extract, dipeptide-2, lactic acid, Superoxide dismutase (SOD), evening primrose (Oenothera biennis) oil, ceramide, dipalmitoyl hydroxyproline, hydroxystearic acid, salicylic acid, ergothioneine, lysolecithin, carnosine, decarboxycarnosine HCL, lipoic acid, adenosine, glycogen, resveratrol, ferula One or more of acid, bifidobacterium culture lysis buffer and lactococcus culture lysis buffer. The content of anti-aging active ingredients in cosmetic compositions is known in the art, eg typically 0.01-10% based on the total weight of component (B).
賦形剤には、例えば、乳化剤、増粘剤、防腐剤、芳香剤等が含まれる。 Excipients include, for example, emulsifiers, thickeners, preservatives, flavoring agents, and the like.
乳化剤の例としては、それだけに限らないが、オリーブ油脂肪酸セテアリル、オリーブ油脂肪酸ソルビタン、ポリソルベート-60、ポリソルベート-80、セスキステアリン酸メチルグルコース、セスキステアリン酸PEG-20メチルグルコース、PEG-40硬化ヒマシ油、PPG-26-ブテス-26、ステアリン酸PEG-4ポリグリセリル-2、PEG-60硬化ヒマシ油、ステアレス-2、ステアレス-21、PPG-13-デシルテトラデセス-24、セテアリルグルコシド、ステアリン酸PEG-100、ステアリン酸グリセリル、ステアリン酸グリセリルSE、ココグルコシド、セテアレス-25、ステアリン酸PEG-40、ジステアリン酸ポリグリセリル-3メチルグルコース、クエン酸ステアリン酸グリセリル、ステアリン酸ポリグリセリル-10、ミリスチン酸ポリグリセリル-10、ジオレイン酸ポリグリセリル-10、ラウリン酸ポリグリセリル-10、イソステアリン酸ポリグリセリル-10、オレイン酸ポリグリセリル-10、ジイソステアリン酸ポリグリセリル-10、ラウリン酸ポリグリセリル-6、ミリスチン酸ポリグリセリル-6、ステアリン酸スクロース、及びポリステアリン酸スクロースの1つ又は複数が挙げられる。化粧品組成物中の乳化剤の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で0.5~10%である。 Examples of emulsifiers include, but are not limited to, cetearyl oleate, sorbitan oleate, polysorbate-60, polysorbate-80, methylglucose sesquistearate, PEG-20 methylglucose sesquistearate, PEG-40 hydrogenated castor oil, PPG -26-buteth-26, PEG-4 polyglyceryl-2 stearate, PEG-60 hydrogenated castor oil, steareth-2, steareth-21, PPG-13-decyltetradeceth-24, cetearyl glucoside, PEG- stearate 100, glyceryl stearate, glyceryl stearate SE, cocoglucoside, ceteareth-25, PEG-40 stearate, polyglyceryl-3 methylglucose distearate, glyceryl stearate citrate, polyglyceryl-10 stearate, polyglyceryl-10 myristate, Polyglyceryl-10 dioleate, polyglyceryl-10 laurate, polyglyceryl-10 isostearate, polyglyceryl-10 oleate, polyglyceryl-10 diisostearate, polyglyceryl-6 laurate, polyglyceryl-6 myristate, sucrose stearate, and polystearic acid one or more of sucrose. The content of emulsifiers in cosmetic compositions is known in the art, eg typically 0.5-10% based on the total weight of component (B).
増粘剤の例としては、それだけに限らないが、カルボマー、アクリレート及びその誘導体、キサンタンガム、アラビアガム、ポリエチレングリコール-14M、ポリエチレングリコール-90M、スクシニル多糖、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ならびにヒドロキシプロピルメチルセルロースなどの高分子ポリマーの1つ又は複数が挙げられる。化粧品組成物中の増粘剤の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で0.1~10%である。 Examples of thickening agents include, but are not limited to, carbomer, acrylates and derivatives thereof, xanthan gum, gum arabic, polyethylene glycol-14M, polyethylene glycol-90M, succinyl polysaccharides, hydroxyethylcellulose, hydroxypropylcellulose, and hydroxypropylmethylcellulose. and one or more of the macromolecular polymers of The content of thickeners in cosmetic compositions is known in the art, eg typically 0.1-10% based on the total weight of component (B).
防腐剤の例としては、それだけに限らないが、ヒドロキシ安息香酸メチル、ヒドロキシ安息香酸プロピル、フェノキシエタノール、ベンジルアルコール、フェニルエタノール、ビス(ヒドロキシメチル)イミダゾリジニル尿素、ソルビン酸カリウム、安息香酸ナトリウム、クロルフェネシン(chlorophenesin)、デヒドロ酢酸ナトリウム、カプリルヒドロキサム酸、1,2-ヘキサンジオール、1,2-ペンタンジオール、p-ヒドロキシアセトフェノン、カプリリルグリコール、カプリル酸グリセリル、ウンデシレン酸グリセリル、カプリル酸ソルビタン、エチルヘキシルグリセロール、及びシャクヤク根抽出物の1つ又は複数が挙げられる。化粧品組成物中の防腐剤の含有量は当技術分野で既知であり、例えば、典型的には成分(B)の総重量基準で0.01~2%である。 Examples of preservatives include, but are not limited to, methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, benzyl alcohol, phenyl ethanol, bis(hydroxymethyl) imidazolidinyl urea, potassium sorbate, sodium benzoate, chlorphenesin ( chlorophenesin), sodium dehydroacetate, caprylhydroxamic acid, 1,2-hexanediol, 1,2-pentanediol, p-hydroxyacetophenone, caprylyl glycol, glyceryl caprylate, glyceryl undecylenate, sorbitan caprylate, ethylhexylglycerol, and One or more of peony root extracts may be included. The content of preservatives in cosmetic compositions is known in the art, eg typically 0.01-2% based on the total weight of component (B).
本発明によるアンチエイジング化粧品組成物は、当技術分野で既知の適切な方法のいずれかによって調製することができる。例えば、溶解タンク、乳化ポット、分散機、移送ポンプ等などの化粧品の分野で一般的に使用される装置を使用して組成物を調製することができる。調製中、水溶性物質を水相溶解ケトルに装入し、油溶性物質を油相溶解ケトルに装入し、2つのケトルをそれぞれ約80℃に加熱する;凝集した原材料の場合、分散機を使用して事前に分散させることができる。溶解が完了したら、油相と水相を乳化ポットに移し、約5~15分間均質化及び乳化する。乳化が完了したら、バルクを室温まで冷却し、場合により芳香剤、防腐剤などを添加し、必要に応じて製品のpHを調整する。 Anti-aging cosmetic compositions according to the present invention can be prepared by any suitable method known in the art. For example, the composition can be prepared using equipment commonly used in the cosmetic field, such as dissolving tanks, emulsifying pots, dispersers, transfer pumps, and the like. During preparation, the water-soluble substance is charged into the aqueous phase dissolution kettle, the oil-soluble substance is charged into the oil phase dissolution kettle, and the two kettles are each heated to about 80°C; Can be pre-dispersed using Once dissolution is complete, the oil and water phases are transferred to an emulsifying pot and homogenized and emulsified for about 5-15 minutes. Once emulsification is complete, the bulk is cooled to room temperature, optionally adding fragrances, preservatives, etc. and adjusting the pH of the product as necessary.
上記の調製方法は、製品形態の要件に応じて変更又は調整することができる。アンチエイジング化粧品組成物は、軟膏、クリーム、ミルク、ローション、エッセンス等などの種々の製品形態に調製することができる。 The above preparation method can be changed or adjusted according to the requirements of the product form. Anti-aging cosmetic compositions can be prepared into various product forms such as ointments, creams, milks, lotions, essences and the like.
例
本発明を、例を参照して、さらに以下で詳細に説明する。しかしながら、これらの例及び比較例は、本発明を具体的に説明するためにのみ使用され、いかなる様式でも本発明の添付の特許請求の範囲を限定するものと理解されるべきではない。
Examples The invention is explained in further detail below with reference to examples. However, these examples and comparative examples are used only to illustrate the invention and should not be construed as limiting the scope of the appended claims of the invention in any way.
例1:老化関連遺伝子の発現に対するカバノキ樹液原液及び濃縮カバノキ樹液の効果
この例では、老化関連遺伝子の発現に対する、カバノキ樹液原液及び様々な濃縮度を有する濃縮カバノキ樹液の効果を試験し、比較した。
Example 1: Effect of undiluted birch sap and concentrated birch sap on the expression of senescence-related genes In this example, the effects of undiluted birch sap and concentrated birch sap with varying degrees of concentration were tested and compared on the expression of senescence-related genes. .
1.カバノキ樹液の濃縮
Daxinganling Chaoyue Wild Berry Development Co.,Ltd.から購入した新鮮なカバノキ樹液(シラカバ(Betula Alba)樹液)原液を、低温乾燥装置に導入し、-65℃に冷却し、0.1Paに真空引きし、1.05倍、1.1倍、1.2倍、1.5倍、2倍、4倍、8倍の程度までそれぞれ濃縮した。
1. Birch Sap Concentration Daxinganling Chaoyue Wild Berry Development Co.; , Ltd. Fresh birch sap (Betula Alba sap) stock solution, purchased from They were concentrated to 1.2-fold, 1.5-fold, 2-fold, 4-fold and 8-fold, respectively.
2.試験
実験機器:蛍光定量PCR(Roche)、クリーンベンチ(Su Jing)、CO2インキュベーター(Binder)、マイクロプレートリーダー(BIO-TEK)、マイクロオシレーター。
実験試薬及び材料:ヒト初代線維芽細胞、6ウェル培養プレート、線維芽細胞用培養培地、RNA抽出キット、逆転写キット、Trizol溶解緩衝液等。
2. Testing Experimental equipment: Fluorescent Quantitative PCR (Roche), Clean Bench (Su Jing), CO2 Incubator (Binder), Microplate Reader (BIO-TEK), Micro Oscillator.
Experimental reagents and materials: human primary fibroblasts, 6-well culture plate, fibroblast culture medium, RNA extraction kit, reverse transcription kit, Trizol lysis buffer, etc.
線維芽細胞に基づく遺伝子発現の分析ステップは以下の通りであった:
(1)接種:細胞を6ウェル培養プレートに5E5細胞/ウェルの密度で接種し、5%CO2を含むインキュベーターで、37℃で一晩インキュベートした;
(2)投与:6ウェル培養プレートの細胞播種率が約60%に達したら、各群の試験物質をそこに添加し、試験物質の各群に6複製ウェルを提供した;
(3)試料回収:5%CO2を含むインキュベーターに、37℃で24時間接種した後、培養培地を廃棄し、各ウェルに1mLのTrizolを添加し、細胞を溶解した後、試料を回収した;
(4)PCR検出:RNAを抽出し、cDNAに逆転写し、蛍光定量PCRによって検出した;
(5)分析:2-ΔΔCT法を使用して結果を計算し、T検定法を統計分析に使用した。
The steps of fibroblast-based gene expression analysis were as follows:
(1) Seeding: Cells were seeded into 6-well culture plates at a density of 5E5 cells/well and incubated overnight at 37°C in an incubator containing 5% CO2 ;
(2) Administration: when the cell seeding rate of the 6-well culture plate reached about 60%, each group of test substances was added thereto, providing 6 replicate wells for each group of test substances;
(3) Sample collection: After inoculation in an incubator containing 5% CO2 for 24 hours at 37°C, the culture medium was discarded, 1 mL of Trizol was added to each well to lyse the cells, and then the samples were collected. ;
(4) PCR detection: RNA was extracted, reverse transcribed into cDNA and detected by fluorescent quantitative PCR;
(5) Analysis: The 2 -ΔΔCT method was used to calculate the results, and the T-test method was used for statistical analysis.
試験結果を以下の表に示した。
上記の結果は、カバノキ樹液原液と比較して、1.1~4倍の濃縮度を有するカバノキ樹液濃縮物が、線維芽細胞に基づくアンチエイジング関連遺伝子の発現レベルを有意に増加させ、特に濃縮度が1.2~2倍の場合に、I型コラーゲン、III型コラーゲン、IV型コラーゲン、VII型コラーゲン、エラスチン及びラミニンの遺伝子発現レベルが全て、カバノキ樹液原液の遺伝子発現レベルよりも有意に高いことを示した。 The above results show that compared to birch sap stock solution, birch sap concentrate with 1.1- to 4-fold enrichment significantly increased the expression level of fibroblast-based anti-aging related genes, especially enriched Gene expression levels of type I collagen, type III collagen, type IV collagen, type VII collagen, elastin and laminin are all significantly higher than those of birch sap undiluted solution when the degree is 1.2-2 fold. showed that
例2:アンチエイジング関連タンパク質の発現に対するカバノキ樹液原液及び濃縮カバノキ樹液の効果
この例では、アンチエイジング関連タンパク質の発現に対する、カバノキ樹液原液及び様々な濃縮度を有する濃縮カバノキ樹液の効果を試験し、比較した。
Example 2: Effect of undiluted birch sap and concentrated birch sap on the expression of anti-aging related proteins In this example, the effect of undiluted birch sap and concentrated birch sap with varying degrees of concentration on the expression of anti-aging related proteins was tested, compared.
1.カバノキ樹液の濃縮
Daxinganling Chaoyue Wild Berry Development Co.,Ltd.から購入した新鮮なカバノキ樹液(シラカバ(Betula Alba)樹液)原液を、低温乾燥装置に導入し、-65℃に冷却し、0.1Paに真空引きし、1.05倍、1.1倍、1.2倍、1.5倍、2倍、4倍、8倍の程度までそれぞれ濃縮した。
1. Birch Sap Concentration Daxinganling Chaoyue Wild Berry Development Co.; , Ltd. Fresh birch sap (Betula Alba sap) stock solution, purchased from They were concentrated to 1.2-fold, 1.5-fold, 2-fold, 4-fold and 8-fold, respectively.
2.試験
実験機器:クリーンベンチ(Su Jing)、免疫洗浄マイクロプレートウォッシャー(BIO-RAD)、マイクロプレートリーダー(BIO-TEK)、CO2インキュベーター(Binder)。
実験試薬及び材料:ヒト初代線維芽細胞、12ウェル培養プレート、線維芽細胞用培養培地、様々な指標用のELISAキット等。
2. Testing Laboratory equipment: clean bench (Su Jing), immunowash microplate washer (BIO-RAD), microplate reader (BIO-TEK), CO 2 incubator (Binder).
Experimental reagents and materials: human primary fibroblasts, 12-well culture plates, fibroblast culture medium, ELISA kits for various indicators, etc.
試験手順は以下の通りとした:
(1)接種:細胞を12ウェル培養プレートに2E5細胞/ウェルの密度で接種し、5%CO2を含むインキュベーターで、37℃でインキュベートし、培養培地を2日毎に交換した;
(2)投与:12ウェル培養プレートの細胞播種率が約60%に達したら、各群の試験物質をそこに添加し、試験物質の各群に6複製ウェルを提供した;
(3)試料回収:5%CO2を含むインキュベーターに、37℃で48時間接種した後、培養培地を廃棄し、各ウェルに1mLのTrizolを添加し、細胞を溶解した後、試料を回収した;
(4)検出:指標はELISAキットの決定方法に従って決定した。
(5)分析:T検定法を統計分析に使用した。
The test procedure was as follows:
(1) Inoculation: Cells were seeded into 12-well culture plates at a density of 2E5 cells/well, incubated at 37°C in an incubator containing 5% CO2 , and the culture medium was changed every two days;
(2) Administration: When the cell seeding rate of the 12-well culture plate reached about 60%, each group of test substance was added thereto, providing 6 replicate wells for each group of test substance;
(3) Sample collection: After inoculation in an incubator containing 5% CO2 for 48 hours at 37°C, the culture medium was discarded, 1 mL of Trizol was added to each well to lyse the cells, and then the samples were collected. ;
(4) Detection: Indicators were determined according to the determination method of the ELISA kit.
(5) Analysis: T-test method was used for statistical analysis.
試験結果を以下の表に示した。
上記の結果は、カバノキ樹液原液と比較して、1.1~4倍の濃縮度を有するカバノキ樹液濃縮物が、線維芽細胞に基づくアンチエイジング関連タンパク質の発現レベルを有意に増加させ、特に濃縮度が1.2~2倍の場合に、I型コラーゲン、III型コラーゲン、IV型コラーゲン、VII型コラーゲン、エラスチン及びラミニンのタンパク質発現レベルが全て、カバノキ樹液原液の遺伝子発現レベルよりも有意に高いことを示した。 The above results show that compared to birch sap stock solution, birch sap concentrate with 1.1- to 4-fold enrichment significantly increased the expression level of fibroblast-based anti-aging related proteins, especially enriched The protein expression levels of collagen type I, collagen type III, type IV, type VII, elastin and laminin are all significantly higher than the gene expression level of the birch sap undiluted solution when the degree is 1.2-2 fold. showed that
例3:組織(組換え3D全層皮膚モデル)に対するカバノキ樹液原液及び濃縮カバノキ樹液の効果
この例では、組換え3D全層皮膚モデルに対する、カバノキ樹液原液及び様々な濃縮度を有する濃縮カバノキ樹液の効果を試験し、比較した。
Example 3: Effect of Birch Sap Stock Solution and Concentrated Birch Sap on Tissue (Recombinant 3D Full Thickness Skin Model) Effects were tested and compared.
1.カバノキ樹液の濃縮
Daxinganling Chaoyue Wild Berry Development Co.,Ltd.から購入した新鮮なカバノキ樹液(シラカバ(Betula Alba)樹液)原液を、逆浸透循環装置に導入し、操作圧力を0.5~5barで制御し、温度を20~35℃にし、カバノキ樹液が1.1倍、1.2倍、1.5倍、2倍及び4倍の程度までそれぞれ濃縮されるまで循環させた。
1. Birch Sap Concentration Daxinganling Chaoyue Wild Berry Development Co.; , Ltd. A fresh birch sap (Betula Alba sap) stock solution purchased from PT. Circulated until concentrated to the extent of .1, 1.2, 1.5, 2 and 4 times respectively.
2.試験方法
実験機器:クリーンベンチ(Su Jing)、インキュベーター(Binder)、UVA及びUVB照射器、マイクロプレートリーダー(BIO-TEK)、凍結ミクロトーム(Leica)。
実験試薬及び材料:3D全層皮膚モデル(実験室で自作)、様々な指標用のELISAキット、MTT(3-(4,5-ジメチルチアゾール-2-イル)-2,5-ジフェニルテトラゾリウムブロミド)キット等。
2. Test method Laboratory equipment: clean bench (Su Jing), incubator (Binder), UVA and UVB irradiator, microplate reader (BIO-TEK), freezing microtome (Leica).
Experimental reagents and materials: 3D full-thickness skin model (homemade in the lab), ELISA kits for various indicators, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) kit etc.
試験手順は以下の通りとした:
(1)3D全層皮膚モデルの構築:3D全層皮膚モデルを、ケラチノサイト及び線維芽細胞を使用して構築した;
(2)モデリング及び投与:モデルが工場を出るとき、すなわち0日目に、SSUV照射処理(UVA:30J/cm2;UVB:50mJ/cm2)を毎日行い、次いで、一定量の試料を対応するモデルの表面に施用した;モデル対照では、モデル培養培地のみを施用し、試験物質の各群に6複製ウェルを提供し、1日1回、合計4日間施用を行った;
(3)試料回収及び検出:モデリング及び投与後、培養培地を回収し、ELISAキットを使用してMMP-1(マトリックスメタロプロテイナーゼ1)を決定した;試験物質の各群から3つのモデルを取得し、MTTキットを使用して細胞増殖生存率を決定してMTT値を得て;残りの3つのモデルを組織固定及びIHC染色に供して、表皮と真皮との間の接合部のIV型コラーゲンの含有量を決定した;
(4)分析:T検定法を統計分析に使用した。
The test procedure was as follows:
(1) Construction of 3D full-thickness skin model: A 3D full-thickness skin model was constructed using keratinocytes and fibroblasts;
(2) Modeling and dosing: When the model leaves the factory, i.e. day 0, SSUV irradiation treatment (UVA: 30 J/cm 2 ; UVB: 50 mJ/cm 2 ) is performed daily, and then a constant amount of sample is applied to the corresponding model control, model culture medium alone was applied, providing 6 replicate wells for each group of test substances, applications were performed once daily for a total of 4 days;
(3) Sample collection and detection: After modeling and dosing, culture medium was collected and MMP-1 (matrix metalloproteinase 1) was determined using an ELISA kit; 3 models were obtained from each group of test substances. , MTT kit was used to determine cell proliferation viability to obtain MTT values; determined the content;
(4) Analysis: T-test method was used for statistical analysis.
試験結果を以下の表に示した。
MTT値の結果は、カバノキ樹液原液と比較して、1.1~4倍の濃縮度を有するカバノキ樹液濃縮物が、3D全層皮膚モデルの組織活力を有意に増加させることを示した。同様に、1.1~4倍の濃縮度を有するカバノキ樹液濃縮物を使用した表皮と真皮との間の接合部でのIV型コラーゲンの相対的発現レベルは、カバノキ樹液原液のレベルよりも有意に高かった。MMP-1の結果は、1.1~4倍の濃縮度を有するカバノキ樹液濃縮物がカバノキ樹液原液よりも有意に優れていることを示した。上記の結果はまた、カバノキ樹液の濃縮度が1.1~2倍の場合に、組換え3D全層皮膚モデルの組織活力を有意に改善し、表皮と真皮との間の接合部でIV型コラーゲンの相対的発現レベルを促進し、細胞外マトリックスにおけるMMP-1の発現を減少させることができることを示した。 The MTT value results showed that birch sap concentrates with 1.1- to 4-fold concentration significantly increased the tissue vitality of the 3D full-thickness skin model compared to the birch sap undiluted solution. Similarly, the relative expression levels of type IV collagen at the junction between epidermis and dermis using birch sap concentrates with 1.1- to 4-fold enrichments were significantly higher than those of birch sap undiluted solution. was expensive. The MMP-1 results showed that birch sap concentrates with 1.1- to 4-fold enrichment were significantly superior to birch sap stock solutions. The above results also show that the tissue vitality of the recombinant 3D full-thickness skin model is significantly improved when the concentration of birch sap is 1.1- to 2-fold, with type IV We have shown that the relative expression levels of collagen can be enhanced and the expression of MMP-1 in the extracellular matrix can be decreased.
例4:アンチエイジングフェイスクリーム組成物の調製
アンチエイジングフェイスクリーム組成物の配合を以下の表に示した:
アンチエイジングフェイスクリーム組成物を以下のように調製した:
1.油相:原材料4、6、7、8、9、11、12、13、15及び21を油相ポットに添加し、80℃に加熱し、溶解し、よく混合した;
2.原材料2、16及び18を室温でよく混合した;
3.原材料10、14、17、20を室温でよく混合した;
4.水相:原材料1、3及び5を80℃に加熱し、ステップ2からの混合物を添加し、溶解し、よく混合した;
5.乳化:水相と油相を乳化タンクに添加し、80℃に保持し、3000rpmで5分間均質化及び乳化し、乳化が完了したら、原材料19を添加した;
6.攪拌しながら40℃に冷却する際、ステップ3からの混合物を添加し、よく攪拌し、排出してアンチエイジングフェイスクリーム組成物を得た。
An anti-aging face cream composition was prepared as follows:
1. Oil phase: Raw materials 4, 6, 7, 8, 9, 11, 12, 13, 15 and 21 were added to the oil phase pot, heated to 80°C, dissolved and mixed well;
2. Raw materials 2, 16 and 18 were mixed well at room temperature;
3. Raw materials 10, 14, 17, 20 were mixed well at room temperature;
4. Aqueous phase: Raw materials 1, 3 and 5 were heated to 80°C and the mixture from step 2 was added, dissolved and mixed well;
5. Emulsification: Add water phase and oil phase to emulsification tank, hold at 80°C, homogenize and emulsify at 3000 rpm for 5 minutes, add raw material 19 when emulsification is completed;
6. Upon cooling to 40° C. with stirring, the mixture from step 3 was added, stirred well and discharged to obtain an anti-aging face cream composition.
この例では、組換え3D全層皮膚モデルに対するアンチエイジングクリーム組成物の効果を試験した。 In this example, the effect of an anti-aging cream composition on a recombinant 3D full thickness skin model was tested.
結果は、アンチエイジングクリーム組成物が、組換え3D全層皮膚モデルの組織活力を極めて有意に増加させ、表皮と真皮との間の接合部でIV型コラーゲンの相対的発現レベルを促進し、細胞外マトリックスにおけるMMP-1の発現を減少させることができることを示した。 The results show that the anti-aging cream composition very significantly increased the tissue vitality of the recombinant 3D full-thickness skin model, promoted the relative expression levels of type IV collagen at the junction between the epidermis and dermis, and the cell We have shown that the expression of MMP-1 in the outer matrix can be decreased.
例5:アンチエイジングアイクリーム組成物の調製
アンチエイジングアイクリーム組成物の配合を以下の表に示した:
アンチエイジングアイクリーム組成物を以下のように調製した:
1.油相:原材料3、5、6、7、9及び11を油相ポットに添加し、80℃に加熱し、溶解し、よく混合した;
2.原材料2及び16を室温でよく混合した;
3.原材料10、14及び17を室温でよく混合した;
4.水相:原材料1、4、8、13、18、19及び20を80℃に加熱し、ステップ2からの混合物を添加し、溶解し、よく混合した;
5.乳化:水相と油相を乳化タンクに添加し、80℃に保持し、3000rpmで5分間均質化及び乳化し、乳化が完了したら、原材料12及び15を添加した;
6.攪拌しながら40℃に冷却する際、ステップ3からの混合物を添加し、よく攪拌し、排出してアンチエイジングアイクリーム組成物を得た。
An anti-aging eye cream composition was prepared as follows:
1. Oil phase: Raw materials 3, 5, 6, 7, 9 and 11 were added to the oil phase pot, heated to 80°C, dissolved and mixed well;
2. Ingredients 2 and 16 were mixed well at room temperature;
3. Raw materials 10, 14 and 17 were mixed well at room temperature;
4. Aqueous phase: Raw materials 1, 4, 8, 13, 18, 19 and 20 were heated to 80°C and the mixture from step 2 was added, dissolved and mixed well;
5. Emulsification: Add water phase and oil phase to emulsification tank, hold at 80°C, homogenize and emulsify at 3000 rpm for 5 minutes, add ingredients 12 and 15 when emulsification is completed;
6. Upon cooling to 40° C. with stirring, the mixture from step 3 was added, stirred well and discharged to obtain an anti-aging eye cream composition.
顔半分対照試験法を使用して、20人の対象を製品を使用する前と製品使用の4週間後で以下の通り試験した:
1)Primosを使用して対象の左右の目尻を撮影し、ソフトウェアを使用して、しわの量、しわの面積、しわの深さ等を含むしわのパラメータを計算した;及び
2)Corneometerを使用して、左右の目尻の皮膚水分量を試験した;
Using a half-face control test method, 20 subjects were tested before using the product and after 4 weeks of using the product as follows:
1) Primos was used to photograph the subject's left and right outer corners of the eye, and software was used to calculate wrinkle parameters, including wrinkle volume, wrinkle area, wrinkle depth, etc.; and 2) using Corneometer. and tested the skin moisture content of the left and right corners of the eyes;
結果は、20人のうち18人の対象が、目尻の皮膚水分量が有意に増加し、このうち15人が有意に浅く軽い目のしわ、しわ面積の減少、及びしわの量の減少を示した。 The results showed that 18 out of 20 subjects had significantly increased skin hydration in the outer corner of the eye, and 15 of these had significantly shallower and lighter eye wrinkles, decreased wrinkle area, and decreased wrinkle volume. Ta.
例6:アンチエイジングエマルジョン組成物の調製
アンチエイジングエマルジョン組成物の配合は以下の通りとした:
アンチエイジングエマルジョン組成物を以下のように調製した:
1.油相:原材料4、5、6、7、12及び13を油相ポットに添加し、80℃に加熱し、溶解し、よく混合した;
2.原材料2、8及び11を室温でよく混合した;
3.原材料9、10及び16を室温でよく混合した;
4.水相:原材料1、3及び14を80℃に加熱し、ステップ2からの混合物を添加し、溶解し、よく混合した;
5.乳化:水相と油相を乳化タンクに添加し、80℃に保持し、3000rpmで5分間均質化及び乳化し、乳化が完了したら、原材料15を添加した;
6.攪拌しながら40℃に冷却する際、ステップ3からの混合物を添加し、よく攪拌し、排出してアンチエイジングエマルジョン組成物を得た。
An anti-aging emulsion composition was prepared as follows:
1. Oil phase: Raw materials 4, 5, 6, 7, 12 and 13 were added to the oil phase pot, heated to 80°C, dissolved and mixed well;
2. Raw materials 2, 8 and 11 were mixed well at room temperature;
3. Ingredients 9, 10 and 16 were mixed well at room temperature;
4. Aqueous Phase: Raw materials 1, 3 and 14 were heated to 80° C. and the mixture from step 2 was added, dissolved and mixed well;
5. Emulsification: Add water phase and oil phase to emulsification tank, hold at 80°C, homogenize and emulsify at 3000 rpm for 5 minutes, add raw material 15 when emulsification is completed;
6. Upon cooling to 40° C. with stirring, the mixture from step 3 was added, stirred well and discharged to obtain an anti-aging emulsion composition.
20人の対象をエマルジョン組成物で4週間処置し、主観的評価を行った。その中で、18人が皮膚水分量の有意な増加及び滑らかで繊細で弾力のある皮膚を報告し;16人がほうれい線及び目のしわの有意な改善を報告した。 Twenty subjects were treated with the emulsion composition for four weeks and subjected to subjective evaluation. Among them, 18 reported a significant increase in skin hydration and smooth, delicate and elastic skin; 16 reported significant improvement in nasolabial folds and eye wrinkles.
例7:アンチエイジングエッセンス組成物
アンチエイジングエッセンス組成物の配合を以下の表に示した:
アンチエイジングエッセンス組成物を以下のように調製した:
1.原材料1、2、3、4、6、12及び13を乳化タンクに添加し、80℃に保持した;
2.原材料5、10及び11を室温でよく混合した;
3.原材料7、8及び9を室温でよく混合した;
4.原材料14を添加し、pHを調整した;
5.攪拌しながら40℃に冷却する際、原材料15及び16ならびにステップ3からの混合物を添加し、よく攪拌し、排出してアンチエイジングエッセンス組成物を得た。
An anti-aging essence composition was prepared as follows:
1. Raw materials 1, 2, 3, 4, 6, 12 and 13 were added to the emulsification tank and held at 80°C;
2. Raw materials 5, 10 and 11 were mixed well at room temperature;
3. Ingredients 7, 8 and 9 were mixed well at room temperature;
4. Raw material 14 was added and the pH was adjusted;
5. Upon cooling to 40° C. with stirring, raw materials 15 and 16 and the mixture from step 3 were added, stirred well and discharged to obtain an anti-aging essence composition.
顔半分対照試験法を使用して、20人の対象を製品を使用する前と製品使用の8週間後で以下の通り試験した:
1)Primosを使用して対象の左右の目尻を撮影し、ソフトウェアを使用して、しわの量、しわの面積、しわの深さ等を含むしわのパラメータを計算した;
2)Corneometerを使用して、左右の目尻の皮膚水分量を試験した;
3)Tewameterを使用して、左右の頬の経表皮水分蒸散量(TEWL値)を試験した。
Using a half-face control test method, 20 subjects were tested before using the product and after 8 weeks of using the product as follows:
1) Primos was used to photograph the subject's left and right outer corners of the eye, and software was used to calculate wrinkle parameters, including wrinkle amount, wrinkle area, wrinkle depth, etc.;
2) The corneometer was used to test the skin hydration of the left and right outer corners of the eyes;
3) The transepidermal water loss (TEWL value) of the left and right cheeks was tested using a Tewameter.
結果は、20人のうち18人の対象が、目尻の皮膚水分量が有意に増加し、このうち15人が有意に浅く軽い目のしわ、しわ面積の減少、及びしわの量の減少を示した。20人のうち18人の対象が、皮膚水分量が有意に増加し、TEWL値が有意に減少し、このうち16人が有意に浅く軽いほうれい線及び目のしわ、しわ面積の減少、ならびにしわの量の減少を示した。 The results showed that 18 out of 20 subjects had significantly increased skin hydration in the outer corner of the eye, and 15 of these had significantly shallower and lighter eye wrinkles, decreased wrinkle area, and decreased wrinkle volume. Ta. Eighteen of the 20 subjects had significantly increased skin hydration and significantly decreased TEWL values, of which 16 had significantly shallower and lighter nasolabial folds and eye wrinkles, decreased wrinkle area, and It showed a reduction in the amount of wrinkles.
上記の例の技術的解決策は、本発明の好ましい実施形態である。本発明の精神及び原理から逸脱することなく、種々の修正及び変形を行うことができ、これらの修正及び変形も本発明の範囲内とみなされるべきである。 The technical solutions in the above examples are preferred embodiments of the present invention. Various modifications and variations may be made without departing from the spirit and principles of the invention, and these modifications and variations should also be considered within the scope of the invention.
Claims (3)
前記アンチエイジング化粧品組成物はさらに添加される水を含まない、使用。 Use of concentrated birch sap in an anti-aging cosmetic composition, said concentrated birch sap having a concentration of 1.1 to 4 times,
Use , wherein said anti-aging cosmetic composition further comprises no added water .
前記アンチエイジング化粧品組成物はさらに添加される水を含まない、アンチエイジング化粧品組成物。 An anti-aging cosmetic composition comprising concentrated birch sap, wherein said concentrated birch sap has a concentration of 1.1 to 4 times,
An anti-aging cosmetic composition, wherein said anti-aging cosmetic composition further comprises no added water .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021212805A JP2022059604A (en) | 2019-07-30 | 2021-12-27 | Anti-aging cosmetic composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910694725.8 | 2019-07-30 | ||
| CN201910694725.8A CN110731928A (en) | 2019-07-30 | 2019-07-30 | Anti-aging cosmetic composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021212805A Division JP2022059604A (en) | 2019-07-30 | 2021-12-27 | Anti-aging cosmetic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021020886A JP2021020886A (en) | 2021-02-18 |
| JP7329474B2 true JP7329474B2 (en) | 2023-08-18 |
Family
ID=69267792
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020055582A Active JP7329474B2 (en) | 2019-07-30 | 2020-03-26 | Anti-aging cosmetic composition |
| JP2021212805A Withdrawn JP2022059604A (en) | 2019-07-30 | 2021-12-27 | Anti-aging cosmetic composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021212805A Withdrawn JP2022059604A (en) | 2019-07-30 | 2021-12-27 | Anti-aging cosmetic composition |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JP7329474B2 (en) |
| CN (1) | CN110731928A (en) |
| WO (1) | WO2021017833A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021020884A (en) * | 2019-07-30 | 2021-02-18 | ヤンシェンタン(アンジ)・コスメティックス・カンパニー・リミテッド | Topical composition for skin having itching relieving effect |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110731925A (en) * | 2019-07-30 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Whitening cosmetic composition |
| CN110731928A (en) * | 2019-07-30 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Anti-aging cosmetic composition |
| CN110731973A (en) * | 2019-07-30 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Skin external composition with anti-inflammatory effect |
| CN110731976B (en) * | 2019-07-30 | 2024-02-06 | 浙江养生堂天然药物研究所有限公司 | Hair loss preventing and growing composition |
| CN110876760B (en) * | 2019-11-28 | 2022-09-30 | 浙江养生堂天然药物研究所有限公司 | Skin external composition with wound healing promoting and/or scar repairing effects |
| CN111329810B (en) * | 2020-04-10 | 2022-10-18 | 上海新高姿化妆品有限公司 | Antioxidant anti-aging cosmetic composition |
| CN113332187B (en) * | 2021-06-07 | 2022-04-08 | 泉后(广州)生物科技研究院有限公司 | A kind of permeation-promoting composition containing hot spring water and application thereof |
| CN113288822B (en) * | 2021-06-29 | 2022-08-05 | 上海新高姿化妆品有限公司 | Multi-dimensional anti-wrinkle composition, cosmetic composition and preparation method of cosmetic composition |
| CN113576975B (en) * | 2021-08-25 | 2023-05-26 | 广州市雅创化妆品有限公司 | Easily-absorbed anti-aging composition and preparation method and application thereof |
| CN113768819B (en) * | 2021-09-28 | 2023-05-12 | 山东焦点福瑞达生物股份有限公司 | Preparation method of moisturizing and anti-aging cosmetic composition containing cationic hyaluronic acid |
| CN115998781A (en) * | 2021-10-22 | 2023-04-25 | 伊春菁桦生物科技有限公司 | Application of birch juice separating liquid in treating gout |
| CN115487122A (en) * | 2021-11-09 | 2022-12-20 | 上海漫虹生物科技有限公司 | Gastrodia elata skin-brightening anti-aging cream and preparation method thereof |
| CN115154356B (en) * | 2022-09-07 | 2022-12-06 | 广州集妍化妆品科技有限公司 | Application of collagen composition in preparation of anti-aging product and external cosmetic comprising collagen composition |
| CN115531238A (en) * | 2022-11-07 | 2022-12-30 | 苏州日月年世生物科技有限公司 | Anti-aging composition and preparation method thereof |
| CN116270295B (en) * | 2023-04-07 | 2023-11-10 | 广东丸美生物技术股份有限公司 | Anti-wrinkle composition containing fully-humanized collagen and application thereof |
| FR3153531B1 (en) * | 2023-09-28 | 2026-05-01 | Arboretum Ingredients | Cosmetic active ingredient based on flaxseed mucilage and birch sap. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006131546A (en) | 2004-11-05 | 2006-05-25 | Asahi Kasei Life & Living Corp | Bath salt containing white birch sap |
| WO2018196482A1 (en) | 2017-04-27 | 2018-11-01 | 养生堂(上海)化妆品研发有限公司 | Skin care cosmetic composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001058920A (en) * | 1999-08-20 | 2001-03-06 | Kao Corp | Cosmetics |
| JP2007320921A (en) * | 2006-06-01 | 2007-12-13 | Nitta Gelatin Inc | Cosmetic comprising sap formulated therein |
| JP2008088109A (en) * | 2006-10-02 | 2008-04-17 | Nitta Gelatin Inc | White birch extract composition and cosmetic comprising white birch formulated therein |
| CN105662940B (en) * | 2016-01-05 | 2018-05-18 | 深圳典立生物科技有限公司 | Active compound and preparation method thereof and its application in cosmetics or skin care item |
| CN107019660B (en) * | 2017-04-27 | 2018-05-11 | 养生堂(上海)化妆品研发有限公司 | Moisture-keeping cosmetics composition |
| CN108186527A (en) * | 2018-02-28 | 2018-06-22 | 程苗 | A kind of cosmetic skin-care composition |
| CN108186482A (en) * | 2018-03-31 | 2018-06-22 | 佛山文森特知识产权服务有限公司 | A kind of tender white skin care compositions of water and its application |
| CN109077960A (en) * | 2018-09-13 | 2018-12-25 | 创领化妆品科技(北京)有限公司 | A kind of anti-ageing lightening compositions of white birch myron |
| CN109044929B (en) * | 2018-09-14 | 2021-05-25 | 陶萍 | Skin care lotion with moisturizing, anti-aging, whitening and freckle removing functions |
| CN110731928A (en) * | 2019-07-30 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Anti-aging cosmetic composition |
| CN110731924B (en) * | 2019-07-30 | 2022-05-17 | 浙江养生堂天然药物研究所有限公司 | Enhanced anti-aging cosmetic composition |
-
2019
- 2019-07-30 CN CN201910694725.8A patent/CN110731928A/en active Pending
-
2020
- 2020-03-26 JP JP2020055582A patent/JP7329474B2/en active Active
- 2020-07-15 WO PCT/CN2020/102177 patent/WO2021017833A1/en not_active Ceased
-
2021
- 2021-12-27 JP JP2021212805A patent/JP2022059604A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006131546A (en) | 2004-11-05 | 2006-05-25 | Asahi Kasei Life & Living Corp | Bath salt containing white birch sap |
| WO2018196482A1 (en) | 2017-04-27 | 2018-11-01 | 养生堂(上海)化妆品研发有限公司 | Skin care cosmetic composition |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021020884A (en) * | 2019-07-30 | 2021-02-18 | ヤンシェンタン(アンジ)・コスメティックス・カンパニー・リミテッド | Topical composition for skin having itching relieving effect |
| JP7437951B2 (en) | 2019-07-30 | 2024-02-26 | ヤンシェンタン(アンジ)・コスメティックス・カンパニー・リミテッド | Skin topical composition with antipruritic efficacy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110731928A (en) | 2020-01-31 |
| JP2022059604A (en) | 2022-04-13 |
| WO2021017833A1 (en) | 2021-02-04 |
| JP2021020886A (en) | 2021-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7329474B2 (en) | Anti-aging cosmetic composition | |
| JP7601560B2 (en) | Enhanced anti-aging cosmetic composition | |
| CN110731923B (en) | Enhanced moisturizing cosmetic compositions | |
| KR102198054B1 (en) | Skin care cosmetic composition | |
| CN110731929B (en) | Mixed birch sap and its use in skin care cosmetic compositions | |
| JP7469913B2 (en) | Fermented birch sap and its manufacturing method | |
| JP7320666B2 (en) | Skin topical compositions with enhanced anti-inflammatory efficacy | |
| CN110731927B (en) | Enhanced whitening cosmetic composition | |
| WO2021017877A1 (en) | Whitening cosmetic composition | |
| CN110772459B (en) | Yeast fermented birch juice and application thereof in whitening cosmetic composition | |
| WO2021017912A1 (en) | Moisturizing cosmetic composition | |
| JP2022542404A (en) | Dermal topical compositions with enhanced anti-eczema efficacy | |
| US20070196528A1 (en) | Cosmetic composition based on caper flower bud extract | |
| KR20210025870A (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Ganoderma lucidum, Arnica montana, Buddleja, Thymus vulgaris, Sigesbeckia Orientalis and Rabdosia rubescens as Active Ingredient | |
| HK40020841A (en) | A moisturizing cosmetic composition | |
| HK40020842A (en) | An anti-aging cosmetic composition | |
| JP2023031253A (en) | Topical skin compositions | |
| HK40020837A (en) | An enhanced anti-aging cosmetic composition | |
| HK40020837B (en) | An enhanced anti-aging cosmetic composition | |
| HK40020870A (en) | A whitening cosmetic composition | |
| KR20250124331A (en) | Exosomes derived from birch raw materials and their preparation method | |
| HK40020838A (en) | An enhanced moisturizing cosmetic composition | |
| HK40020838B (en) | An enhanced moisturizing cosmetic composition | |
| HK40020866B (en) | An enhanced whitening cosmetic composition | |
| HK40020866A (en) | An enhanced whitening cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200327 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210125 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210506 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210903 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211227 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20211227 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220127 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220128 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20220218 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20220222 |
|
| C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230201 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230519 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230807 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7329474 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |